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1 Introduction
The elective vaginal delivery of breech presenta-
tion infants has become less frequent due to the
concern of clinicians about perinatal morbidity
and mortality. Thus, cesarean delivery for
breech presentation has increased to reduce or
avoid fetal trauma and/or asphyxia [5]. How-
ever, the risks of vaginal breech delivery can be
avoided if the fetus is manipulated from breech
to cephalic presentation by external cephalic
version (ECV) [6, 9, 13, 14, 16, 17, 18, 20, 21].
Randomized prospective studies have indicated
that 3rd trimester ECV performed with toco-
lysis following real time ultrasound and cardi-
otocography screening, involves minimal fetal
risk and is 60-90% successful [9, 18]. As the
role for late third trimester ECV is not estab-
lished in pregnancies with breech presentation,
we initiated a prospective clinical trial of ECV
to evaluate the safety and utility of the proce-
dure. Our experience constitutes the basis for
this report.
2 Materials and methods
101 patients with normal pregnancy, from pri-
vate and university services were referred for
ECV (figure 1) and prospectively managed by
protocol. Entry requirements were breech pre-
sentation at > 35 weeks from the last menstrual
period and normal gestation.
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Patients excluded from consideration for trial
included those with: 1) a fixed, engaged present-
ing part; 2) multiple gestation; 3) serious medi-
cal disorders of pregnancy (e. g. insulin-requir-
ing diabetes, hypertension, etc.); 4) known or
suspected fetal anomaly; and 5) known or sus-
pected serious pregnancy complications (e. g.,
premature membrane rupture, abruptio
placentae etc.). Initial screening was performed
by clinicians who then referred selected patients
to our research unit for the ECV protocol.
A screening real time ultrasound examination
and an unstressed cardiotocogram (NST) was
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*At Discretion of Operator
Figure 1. Version protocol.
performed. The NST was classified as reactive
and acceptable if two or more fetal heart rate
accelerations of > 15 bps for > 15 seconds was
observed over 20 minutes. Gestational age was
established by menstrual dating and ultrasonic
examination based on biparietal diameter,
head/body ratio and long bone length. Discrep-
ancies exceeding + 2 weeks were reconciled by
pediatric examination of the neonate utilizing
DUBOWITZ criterion with reassignment of dat-
ing if appropriate.
Following informed consent, 0.25 mg. of terbu-
taline sulfate was administered subcutaneously.
Only a single injection was given. Manipula-
tions were performed 30 minutes later. Mineral
oil was applied as a maternal abdominal lubri-
cant. Versions were performed with the patient
supine in TRENDELENBERG'S position. A head-
over-heels technique with the operation at the
patient's right side was preferred. Back-flips as
described by SALING and MÜLLER-HOLVE [14]
were performed if the initial procedure failed.
Firm, but slow movements proved most suc-
cessful. Following manipulations, the fetal
heart was ultrasonically visualized, the rate ob-
served, and fetal position confirmed. Finally, an
additional electronic fetal heart rate monitoring
was performed to assure fetal well being.
If two attempts in each direction failed to
achieve version or the patient proved intolerant
to manipulation, the procedure was terminated.
Rh negative women were administered immu-
noglobulin if any manipulations, either success-
ful or unsuccessful had been performed. KLEIN-
HAUER-BETKE examinations were not performed.
Following the procedure the patients were rest-
ed in left lateral recumbency until the cardioto-
cography was judged normal, thereafter they
were discharged to home. Subsequent manage-
ment was by standard clinical procedures of
the responsible clinician.
Date was analyzed by Chi square or t-test
analysis with p < 0.05 accepted as the level
indicating significance.
3 Results
We attempted version on 85 of 101 patients.
Initial cephalic presentation [11], marked oli-
gohydramnios [3], encephalocele [1], and a non-
reactive, suspicious initial electronic monitoring
tracing [1] led to candidate rejection (figure 2).
In 53/85 cases (62.5%) ECV was successful.
Our requirements for gestational age for trial
of ECV were based on clinical criteria, i. e.,
menstrual dating. We subsequently discovered
that using 35 weeks as a minimum .gestational
age for referral resulted in a patient group with
the eventual assignment of gestational ages
ranging from 33 to 41 weeks (figure 3). When
the date was evaluated for mean maternal age,
gestational age and eventual delivery weight —
all were found to be unrelated to ECV success.
However, parity was observed to be a signifi-
cant factor (tables I, II).
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Figure 3. Success or failure of version attempts by gesta-
tional age (see text for details).
Table I. Version success and maternal age, gestational





Maternal age 25.7 ± 5.4 yrs.** 25.5 ± 5.4 yrs.
Gestational age 38.0 ± 1.5 wkas.** 37.4±1.7wks.
Delivery weight 3481 ± 485 gms.** 3324 ± 400 gms
* Based on N = 81, 4 patients lost to follow-up. See
text for details.










Four patients (4/85 = 4.7%), 2 from each
group, were lost to follow-up (figure 2). One
gravida could not be contacted, two women
had left the state, and one the country prior to
delivery.
Fifty percent of the ECV failure patients subse-
quently delivered by cesarean section. However,
abdominal delivery was required in only 9.8%
(5/51) of those cases in which version had been
successful. Of interest, in three cases spon-
taneous version to cephalic presentation oc-
curred after failed ECV (3/30 = 10.0%) (table
III).
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* Both infants cephalic at delivery. Not fetal or ma-
ternal injury.
** Lethal congenital cardiac defect.
*** Meconium aspiration during vaginal breech deli-
very.
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Table IV outlines the complications observed have aortic atresia. This infant tolerated labor
in the 81 cases for which complete delivery data and was delivered vaginally, but succumbed on
is available. day four during attempted corrective surgery.
4 Discussion
External manipulation of the fetus can convert
60 — 90% of breech presentations to cephalic
depending upon technique, the skill of the op-
erator, use of tocolysis, and the population se-
lected for trial [6, 7, 9, 13, 14, 16, 18, 20, 21].
The relative influence of gravity, uterine shape,
or placentation in eventual fetal polarity is not
established [15, 19]. At the beginning of the 3rd
trimester, 20 — 30% of fetuses present by the
breech. However, as gestation proceeds, enlar-
gement of the fetus, diminution of amniotic
fluid volume, and adjustment of the uterus pre-
dispose to cephalic presentation. Studies of fetal
life note that the infant spontaneously assumes
a cephalic presentation by the 34th week of
gestation in all but 2—4% of normal pregnan-
cies [19]. Thus, if version is attempted in the
early 3rd trimester it is often easy, but fre-
quently unnecessary, and re-version may occur.
However, once a pregnancy passes into the late
3rd trimester, spontaneous version is uncom-
mon (< 15%), and the probability of the exist-
ing presentation persisting to term is high.
These facts must be considered in the critical
evaluation of the role of ECV in the obstetrical
management of malpresentation.
In this study, 16 of 101 patients were excluded
from trial of version by the combined results
of real time ultrasonic scanning and EFM. In
one case, with spontaneous contractions, suspi-
cious decelerations occurred in a pregnancy in
which the fetus was found to be growth retard-
ed. In the other instance, a large fetal encepha-
locele was observed on the initial ultrasound
scan. On initial scanning 11 fetuses were found
to be in cephalic presentation and version was
not attempted. Marked oligohydramnios led to
the exclusion of 3 additional cases early in
the course of the study. Yet, one serious fetal
anomaly was missed. We evaluated and success-
fully verted a fetus that subsequently proved to
Transient fetal heart decelerations frequently
accompany version attempts and were observed
in this series [16]. In some instances maternal
symptoms implied a supine hypertensive syn-
drome likely exacerbated by the abdominal ma-
nipulations of version. In most circumstances,
however, the changes were of unestablished
cause but were likely due to transient cord
compression. In our series, re-version for per-
sisting fetal bradycardia was never necessary
and in no instance was acute delivery required
for conditions arising from the procedure.
However, one compound (head/arm) presenta-
tion occurred following version. In this case,
dystocia ensued during labor and operative de-
livery was necessary. Such complications, albeit
uncommon, have been previously observed [1].
The single serious fetal complication in this
series, meconium aspiration, occurred in a va-
ginally delivered breech infant. An unsuccessful
version attempt had occurred 16 days pre-
viously. While meconium was present in 8 addi-
tional cases, in none was it associated with fetal
distress. A larger series is needed to establish
any association between the manipulations of
version and meconium passage. The other com-
plications observed, cord prolapse, and a mar-
ginal abruptio placentae occurred more than
10 days after ECV and are difficult to ascribe
to the procedure.
Clinically, failure to elevate the presenting part
was the most consistent cause of ECV failure.
We could not discern specific ultrasonic find-
ings that others have reported [7, 10, 20] pre-
dicting success in version, except engagement
of the breech. In our series attempted vaginal
manipulations to dislodge an engaged breech
were in all but one instance unsuccessful as well
as uncomfortable for the patient. In addition,
neither placental locale nor low amnionic fluid
volume (unless marked oligohydramnios was
present) modified our version protocol. None
of the gravids examined in this series had clini-
cal or ultrasonic evidence of placentation suffi-
J. Perinat. Med. 14 (1986)
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ciently low lying to permit the diagnosis of
placenta previa. Further, we did not observe
differences in success based on placental locali-
zation.
Initially, we utilized terbutaline tocolysis only
in cases in which initial manipulation failed to
achieve easy version. However, we soon dis-
covered that betamimetic assisted version was
easier for both patient and operator, and there-
after, we administered tocolytics routinely
(overall in 43/85 or 50.5%). Betamimetics are
not without serious complications, but neither
we nor others have observed complications
from acute administration for ECV [6, 14, 18].
Terbutaline was chosen because of our success-
ful prior experience with this agent; the route
of administration by convenience and economy.
Due to the fact that our patients frequently
traveled long distances for the procedure and
with uncertainties of patient follow-up, we
routinely administered immune globulin to all
Rh negative patients with an ECV attempt [9,
11, 12]. In series in which KLEINHAUER-BETKE
studies have been performed, 4 — 28% of ver-
sion patients have shown evidence of measur-
able fetomaternal bleeding [8, 16].
Based on our experience, factors important to
the success and safety of late third trimester
version include:
1) Operator experience and careful patient se-
lection,
2) The use of firm but smooth movements dur-
ing manipulation,
3) Screening by both real time ultrasound and
electronic fetal heart rate monitoring,
4) The use of tocolysis,
5) A setting permitting prompt intervention if
required.
In sum, while the numbers involved in this trial
are limited, we conclude that major risks do
not accompany late 3rd trimester version if
reasonable care is taken and careful pre-at-
tempt fetal evaluation is performed. However,
practitioners and patients need to remain aware
that fetal manipulations cannot invariably be
free from complications [1, 2, 3, 4, 8, 12]. Thus,
it seems prudent to carefully evaluate the fetus
both anatomically as well as biophysically prior
to an attempt at version in a setting where
intervention, if indicated, is possible.
Summary
Eighty-five normal women underwent external cephalic
version (ECV) for breech presentation in the late 3rd
trimester (figures 1, 2). The protocol included real time
ultrasonic scanning and pre- and post-procedure elec-
tronic fetal monitoring. Subcutaneous terbutaline sulfate
(0,25 mg.) was administered to (43/85 or 50.5%) of ECV
candidates and rendered the procedure easier for patient
and operator. A single operator, head-over-heels tech-
nique assisted by supine TRENDELENBERG'S position was
used. Rh negative women were routinely administered
300 meg of immune globulin. Successful ECV (53/85,
62.5%) was related to maternal parity, but not tp gesta-
tional age nor eventual delivery weight (tables I, II).
There were no acute maternal or fetal complications
referrable to ECV. One neonatal loss occurred due to a
lethal congenital cardiac anomaly (table IV). In this
series only engagement of the breech was reliable in
predicting ECV failure.
Fifty of 51 (98.1%) successfully verted women delivered
a cephalic presentation infant at term. Cesarean section
was performed in 5/51 of these patients (9.8%) for
routine obstetrical indications. In one case, compound
presentation at term resulting in dystocia and eventual
cesarean section was believed related to prior successful
version. In contrast, 15/30 (50%) of the ECV failure
patients went on to operative delivery despite a liberal
institutional policy toward term vaginal breech trials. In
addition, the only serious fetal complication in this
series, meconium aspiration, occurred in a vaginally
delivered breech infant (tables III, IV).
It is unlikely that late 3rd trimester ECV will impact on
our overall rate of cesarean delivery. In North America
prematurity is the greatest risk factor in malpresentation
and our policy increasingly is to permit attempts at
term breech vaginal delivery. Nonetheless, ECV deserves
serious consideration. When successful, ECV avoids the
costs and/or risks of either cesarean section or vaginal
trial of breech. As opposed to version practiced earlier
in gestation, the merit of late 3rd trimester ECV is
that more than 80% of spontaneous versions will have
occurred by the time the procedure is attempted. Thus,
most successful late version procedures occur in cases
J. Perinat. Med. 14 (1986)
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where spontaneous conversion is unlikely. In addition,
babies successfully verted late in gestation are unlikely
to spontaneously revert to breech (1/51 or 2% in our
series).
Keywords: Breech presentation, external cephalic version, late pregnancy tocolysis.
Under the protocol described herein, and in a limited
series of patients, we have found late 3rd trimester ECV
62.5% successful and clinically safe.
Zusammenfassung
Äußere Wendung — ein klinischer Erfahrungsbericht
Wegen Beckenendlage (BEL) im fortgeschrittenen drit-
ten Trimenon wurde bei 85 Frauen eine äußere Wendung
vorgenommen (Abb. l, 2). Zur Protokollierung gehörten
eine Ultraschall-Untersuchung sowie ein elektronisches
Monitoring des Feten vor und nach der Wendung.
Durch subkutane Injektion von 0,25 mg Terbutalinsulfat
bei 43 von 85 Frauen (50.5%) wurde der Vorgang für
Patient und Operateur erleichtert. Die Wendung wurde
im Sinne einer Rückwärtsrolle des Feten durch eine
Person ausgeführt. Rh-negativen Frauen wurde routine-
mäßig 300 g Anti-D verabreicht. Die erfolgreichen
Wendungen (53 von 85, d. h. 62.5%) wurden zur Parität,
nicht aber zum Gestationsalter oder zum geschätzten
Geburtsgewicht in Beziehung gesetzt (Tabellen I, II).
Akute mütterliche oder fetale Komplikationen, die auf
die Wendung zurückzuführen waren, traten nicht auf.
Ein neonataler Todesfall war auf eine angeborene letale
Herzmißbildung zurückzuführen. Über den Erfolg bzw.
Mißerfolg einer Wendung entschied in der Untersu-
chungsreihe allein die Lage des Steißes.
50 von 51 Frauen mit erfolgreicher Wendung (98,1%)
wurden am Termin von einem Kind aus Schädellage
entbunden. Dabei war bei 5 der 51 Frauen (9,8%) aus
verschiedenen geburtshilflichen Gründen eine Sectio in-
diziert. In einem Fall kam es am Termin zu einer Dysto-
kie und schließlich zu einer Sectio; hier glauben wir,
einen Zusammenhang zu der vorher erfolgreich durchge-
führten Wendung herstellen zu können. Auf der anderen
Seite wurden 15 von 30 Frauen (50%) nach erfolgloser
Wendung per Sectio entbunden, obwohl wir bezüglich
vaginaler BEL-Geburten einen liberalen Standpunkt ein-
nehmen. Die einzige ernsthafte Komplikation, eine Me-
koniumaspiration, trat in unserer Untersuchungsreihe
jedoch bei einem Kind nach vaginaler BEL-Geburt auf
(Tabellen III, IV).
Es ist unwahrscheinlich, daß eine Wendung im fortge-
schrittenen dritten Trimenon einen Einfluß auf die Ge-
samtsectiorate hat; in Nordamerika ist Frühgeburtlich-
keit der größte Risikofaktor für BEL. Ein anderer Punkt
ist die Haltung zu vaginalen BEL-Geburten am Termin.
Trotzdem soll die äußere Wendung ernsthaft erwogen
werden; ist sie erfolgreich, werden Kosten und Risiken
einer Sectio bzw. einer vaginalen BEL-Geburt vermie-
den. Der Hauptvorteil gegenüber einem frühen Wen-
dungsversuch liegt darin, daß bei der Wendung im fort-
geschrittenen dritten Trimenon mehr als 80% der Wen-
dungen bereits spontan erfolgt sind. Die späten Wen-
dungsversuche werden also dann durchgeführt, wenn
eine spontane Drehung unwahrscheinlich ist. Hinzu
kommt, daß nach einer erfolgreichen späten Wendung
das Zurückdrehen in die BEL unwahrscheinlich ist (l
von 51 bzw. 2% in unserer Untersuchungsreihe).
Bei der beschriebenen Vorgehensweise und dem begrenz-
ten Kollektiv können wir sagen, daß die äußere Wen-
dung im fortgeschrittenen dritten Trimenon in 62,5%
der Fälle erfolgreich und klinisch sicher war.
Schlüsselwörter: Äußere Wendung, Beckenendlage, Tokolyse in der Spätschwangerschaft.
Resume
Version par manoeuvres externes — experience clinique
Quatre-vingt cinq femmes normales ont subi une version
par manoeuvres externes (VME) a la fin du troisieme
trimestre pour une presentation du siege (figures l, 2).
Le protocole comprenait une echographie en temps reel
et un enregistrement du rythme cardiaque foetal avant
et apres les manoeuvres. On a administre en sous-cutane
du sulfate de terbutaline (0.250 mg> a 43 canditates a la
VME sur 85 (50,5%) ce qui facilitait les manoeuvres
pour les patientes et pour Foperateur.
Un seul Operateur utilisait la technique de la tete sur les
talons aide d'une position de trendelenbourg. Les fem-
mes rhesus negatif ont re$u systematiquement 300 mcg
de gammaglobuline. Les succes de la VME (53/85;
62,5%) sont correles a la parite maternelle, mais ni ä
Tage gestationel, ni au poids de naissance (tableaux I,
II). II n'y a pas eu de complication aigüe maternelle ou
foetale implicable ä la VME. Un deces neonatal est
survenu, secondaire ä une anomalie cardiaque congeni-
tale lethale (tableau IV). Dans cette serie, seul Fengage-
ment du siege etait correle ä la prevision d'un echec de
la VME.
Cinquante des 51 (98,1%) ayant eu une version efficace
ont donne naissance, ä terme, ä un enfant en presenta-
J. Perinat. Med. 14 (1986)
O'Grady et al., External cephalic version 195
tion cephalique. Chez ces patientes, une cesarienne ä ete
pratiquee 5 fois/51 (9,8%) pour des indications obstetri-
cales de routine. Dans un cas, un procubitus d'un mem-
bre a terme a entraine une dystocie et on a considere
la cesarienne comme secondaire a la version efficace
anterieure. A Finverse 15/30 (50%) des patientes ayant
eu un echec de la VME ont subi une cesarienne malgre
une attitude institutionelle liberale face aux sieges ä
terme. En outre, la seule complication foetale severe
dans cette serie, ä savoir une inhalation meconiale, est
survenue chez un enfant en presentation du siege ne par
voie vaginale (tableau III, IV).
II est peu probable que la VME a la fin du troisieme
trimestre influencera le taux global de cesarienne en
Amerique du Nord et ceci pour deux raisons: la premiere
est que la prematurite est encore le facteur de risque le
plus important pour la presentation defavorables, et la
deuxieme est du ä une politique plus liberale de Faccou-
chement du siege par voie basse a terme. Neanmoins, la
VME mnrite une consideration importante. Lorsqu'elle
reussit la VME evite le coüt et/ou les risques de la
cesarienne et de Paccouchement du siege par voie basse.
A Foppose de la version pratiquee plus tot au cours de
la grossesse, le merite de la VME a la fin du troisieme
trimestre est que plus de 80% des versions spontanees
auront deja eu lieu au moment de la tentative. Ainsi,
beaucoup de versions efficaces par monoeuvres externes
tardives surviennent dans des cas ou la version spontanee
est peu probable. En outre, les foetus verses en presenta-
tion cephalique tardivement au cours de la grossesse ont
peu de risque de se retourner spontanement en siege (I/
51 ou 2% dans notre serie).
Selon le protocole decrit ci-dessus et dans une serie
limitee de patientes, nous avons trouve que la VME ä
la fin du troisieme trimestre ä 62,5% de succes et qu'elle
est cliniquement sans danger.
Mots-cles: Presentation du siege, tocolyse de fin de grossesse, version par manoeuvre externe.
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